Acasti Pharma reported $-3.7M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Addus HomeCare USD 39.82M 876K Sep/2026
Amarin USD -2.26M 564K Dec/2025
Cassava Sciences USD -9.39M 1.78M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Option Care Health USD 89.22M 4.08M Sep/2026
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Tilray USD -20.01M 9.34M Sep/2025